5 questions facing emerging biotech in 2025
Bio Pharma Dive
JANUARY 14, 2025
Young drugmakers confront several harsh realities this year, among them a contracting sector and competition from China.
Tue.Jan 14, 2025
310 
Pharma to raise prices on more than 250 drugs in the US from January 2025
Pharmaceutical Technology
JANUARY 14, 2025
This month, pharma companies have announced plans to increase the prices of more than 250 branded drugs in the US.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lilly blames slower-than-expected growth for 2024 sales miss
Bio Pharma Dive
JANUARY 14, 2025
The company said it overestimated demand of its obesity and diabetes drugs in the fourth quarter, but projected a further ramp-up in sales this year.
JP Morgan 2025: Thermo Fisher rides momentum to project strong growth in 2025
Pharmaceutical Technology
JANUARY 14, 2025
The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 performance.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
JPM25: Amgen’s defense, Merck’s patent ‘hill’ and Viking’s long-term planning
Bio Pharma Dive
JANUARY 14, 2025
Executives at Amgen made the case for MariTide's differentiation, while Merck's CEO contended that Keytruda's coming loss of exclusivity can be managed.
Innovative Approaches to Generic Drug Development: Case Studies
Drug Patent Watch
JANUARY 14, 2025
The Generic Drug Revolution: Setting the Stage Before we dive into the nitty-gritty, let’s take a moment to appreciate the impact of generic drugs. Did you know that generic drugs now make up about 90% of all prescription drug purchases in the United States, while accounting for only 20% of prescription drug spending[1]? That’s right, these unsung heroes are saving our healthcare system trillions of dollars!
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Pharmaceutical Technology Excellence Awards 2024: Syngene
Pharmaceutical Technology
JANUARY 14, 2025
Leading CRDMO Syngene is a Triple Category Award winner in the 2024 Pharmaceutical Technology Excellence Awards.
Regenxbio licenses gene therapies to Japan’s Nippon Shinyaku
Bio Pharma Dive
JANUARY 14, 2025
Nippon Shinyaku will pay Regenxbio $110 million upfront for U.S. and Asia rights to treatments for Hunter and Hurler syndromes.
JP Morgan 2025: Novartis streamlines its portfolio to drive future growth
Pharmaceutical Technology
JANUARY 14, 2025
Eight blockbuster drugs are expected to generate over $3bn in peak sales each according to Novartis CEO Vas Narasimhan.
Pheno Therapeutics granted trial authorisation for MS candidate
Pharma Times
JANUARY 14, 2025
First-in-human trial of PTD802 to commence following UK MHRA approval
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m
Pharmaceutical Technology
JANUARY 14, 2025
The acquisition builds on a 2017 option agreement and subsequent 2018 licensing deal with Glycotope.
Grifols pioneers high-tech analysis of plasma bank to detect Parkinson’s disease
Pharma Times
JANUARY 14, 2025
Initiative aims to identify plasma-based biomarkers for early detection
J&J to leverage Intra-Cellular Therapies’ neurology portfolio
Pharmaceutical Technology
JANUARY 14, 2025
Intra-Cellulars clinical-stage pipeline is promising, with pipeline agents under development for a wide range of neurological indications.
FTC again goes after PBMs’ business practices in new report
Bio Pharma Dive
JANUARY 14, 2025
Agency commissioners voted unanimously on Tuesday to publish the report, which makes a similar attack on the drug middlemen as the agency’s first report, but draws on more data.
JP Morgan 2025: Moderna stock suffers after CEO reveals conservative 2025 guidance
Pharmaceutical Technology
JANUARY 14, 2025
CEO Stphane Bancel emphasised saving cash as integral in the companys bid to parlay Covid-19 profits into future profitability.
FDA sets August date for subcutaneous Leqembi decision
pharmaphorum
JANUARY 14, 2025
FDA has started its review of an autoinjector version of Eisai and Biogen's Alzheimer's drug Leqembi that could allow patients to be dosed at home
Normunity raises $75m to advance solid tumour targeting T-cell engagers
Pharmaceutical Technology
JANUARY 14, 2025
US-based biotech Normunity plans to initiate a Phase I clinical trial of NRM-823 in the second half of 2025.
AIs can be used for fracture detection, says NICE
pharmaphorum
JANUARY 14, 2025
NICE has said that four artificial intelligence technologies can be deployed by the NHS to detect fractures on X-rays in urgent care.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Eisai and Biogen’s subcutaneous Leqembi set for FDA review
Pharmaceutical Technology
JANUARY 14, 2025
The PDUFA action date for the more convenient autoinjector is set for August 2025.
Johnson & Johnson acquires Intra-Cellular for $14.6bn
Outsourcing Pharma
JANUARY 14, 2025
Johnson & Johnson's $14.
Enhancing patient engagement and outcomes in the NHS
Pharmaceutical Technology
JANUARY 14, 2025
In a new webinar, industry experts explore how innovative technology and direct patient communication are transforming medication adherence in the UK.
Scope Summit finalists to fight for awards in site innovation and patient engagement
Outsourcing Pharma
JANUARY 14, 2025
Spotlighting innovation at the SCOPE Summit, finalists for the Site Innovation and Patient Engagement Awards showcase groundbreaking tools, AI solutions, and diversity-driven initiatives set to transform clinical trials.
Pharmaceutical Technology Excellence Awards 2024: IFF Pharma Solutions
Pharmaceutical Technology
JANUARY 14, 2025
IFF Pharma Solutions is a winner in the Marketing category in the 2024 Pharmaceutical Technology Excellence Awards.
Grifols gets $21m award for Parkinson's biomarker hunt
pharmaphorum
JANUARY 14, 2025
Grifols has been awarded a $21m grant from the Michael J Fox Foundation to find plasma biomarkers to predict Parkinson's years before symptoms start
JP Morgan 2025: Almirall updates strategy with focus on medical dermatology
Pharmaceutical Technology
JANUARY 14, 2025
In 2023, medical dermatology represented 52% of Almirall's income with a turnover of EUR465.2m ($477.36m).
Delivery: The key to navigating pharmacy deserts in 2025
pharmaphorum
JANUARY 14, 2025
Learn how delivery services are helping to alleviate the impact of pharmacy closures and navigating pharmacy deserts in 2025. Stay informed on the key strategies and solutions.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Clinical research survey results: The key pressures for SMEs and business outlook
Pharmaceutical Technology
JANUARY 14, 2025
Small and medium-sized enterprises (SMEs) in the clinical research space face mounting challenges. Yet a recent survey highlights optimism.
Pharma Pulse 1/14/25: Holding On Tight to AI Wave, the GLP-1 Landscape for Diabetes Care & more
Pharmaceutical Commerce
JANUARY 14, 2025
The latest news for pharma industry insiders.
JP Morgan 2025: reduced dosing and expanded manufacturing paving way for Amgen’s obesity entrance
Pharmaceutical Technology
JANUARY 14, 2025
Amgen presented data about its obesity drug at JP Morgan 2025, stating it hopes the once-monthly dosing will make it an attractive therapy.
Designing a One-Stop-Shop Sampling Platform
Pharmaceutical Commerce
JANUARY 14, 2025
In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Mark Jara, founder and CTO, RxS, shares his inspiration behind designing SampleHub.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Let's personalize your content